Latest Articles

We typically think of a cancerous tumor as a bunch of abnormal cells gone rogue, but the situation is more complicated. This article will explore cell-to-cell communication’s role in cancer development, its influence on metastasis and how research is expanding our knowledge of the disease.

Technology Networks invited Andy Shovel, CEO and co-founder of THIS^TM, a company that develops plant-based alternatives to meat, to an Ask Me Anything session to answer your questions about the latest advances in alternate foods.

Are these fabricated flavorings really any better for us than sugar? Well, they have their good and bad qualities, according to the latest research.

Explore how utilizing technology such as the IoT within the filtration process, brewers can recognize efficiency and quality gains, meet sustainability goals and ultimately deliver that perfect pint to the customer.

Explore how recent technical advances in the design and construction of NMR instrumentation have eliminated practical issues that faced scientists whose experiments would benefit from the power of the technique, but who needed the speed and convenience of analysis unachievable with traditional high-field instruments.

What's the latest research surrounding how vitamin D affects our health? This article dives into how vitamin D deficiency has been linked to increased cancer mortality and more.

Technology Networks spoke to Dr. Gabriela Quinlan, a research fellow in Penn State’s department of entomology and center for pollinator research, to find out why US bees are becoming less productive.

In this interview, Dr. Brandon Vaidyanathan describes what is meant by “beauty” in science, how it can be studied and the implications of such research.

Cell therapy refers to the transplantation of human cells to either replace or repair damaged tissues and/or cells. In this article, we expand upon the applications of cell therapy, including its utility in cancer, regenerative medicine and autoimmunity.

In this article, the latest challenges in interpreting complex genomic cancer profiles and the improvements needed to overcome them are discussed.